Literature DB >> 12834566

Prevention of Cardiovascular Disease in Women.

Omer L. Shedd1, Marian C. Limacher.   

Abstract

Appropriate screening and lifestyle modification are the foundations of effective cardiovascular disease (CVD) prevention in women. All adult women should undergo a cardiovascular risk assessment, including family history, smoking, diet, and exercise assessments, and measurement of fasting lipid profile, waist and hip dimensions, and blood pressure. Women should be advised of their 10-year estimated risk of developing a cardiovascular event using the Framingham risk calculator as recommended by the National Cholesterol Education Program. Based on the level of risk, women should receive counseling on dietary modification, physical activity, weight loss, and the need for pharmacologic intervention for blood pressure, lipid, and diabetes management. In addition, women who are overweight, have a history of gestational diabetes, or family history of diabetes should have a fasting glucose measured. Women who smoke should receive advice, encouragement, and assistance for smoking cessation. Postmenopausal hormone therapy should not be considered a treatment option for primary or secondary prevention of CVD. Women and their families should be advised of the possible signs of CVD and the need to seek immediate medical attention in the event of prolonged, new, or severe symptoms. Women with coronary artery disease especially need close attention to their risk factor levels and should receive intensive intervention to achieve optimal control.

Entities:  

Year:  2003        PMID: 12834566     DOI: 10.1007/s11936-003-0028-6

Source DB:  PubMed          Journal:  Curr Treat Options Cardiovasc Med        ISSN: 1092-8464


  45 in total

1.  Hormone replacement therapy and cardiovascular disease: a statement for healthcare professionals from the American Heart Association.

Authors:  L Mosca; P Collins; D M Herrington; M E Mendelsohn; R C Pasternak; R M Robertson; K Schenck-Gustafsson; S C Smith ; K A Taubert; N K Wenger
Journal:  Circulation       Date:  2001-07-24       Impact factor: 29.690

2.  Women and cardiovascular disease: the risks of misperception and the need for action.

Authors:  R M Robertson
Journal:  Circulation       Date:  2001-05-15       Impact factor: 29.690

3.  American Heart Association call to action: obesity as a major risk factor for coronary heart disease. AHA Nutrition Committee.

Authors:  R H Eckel; R M Krauss
Journal:  Circulation       Date:  1998-06-02       Impact factor: 29.690

Review 4.  The primary prevention of coronary heart disease in women.

Authors:  J W Rich-Edwards; J E Manson; C H Hennekens; J E Buring
Journal:  N Engl J Med       Date:  1995-06-29       Impact factor: 91.245

5.  Evidence for primary and secondary prevention of coronary artery disease in women taking oestrogen replacement therapy.

Authors:  T L Bush
Journal:  Eur Heart J       Date:  1996-08       Impact factor: 29.983

6.  Fish and omega-3 fatty acid intake and risk of coronary heart disease in women.

Authors:  Frank B Hu; Leslie Bronner; Walter C Willett; Meir J Stampfer; Kathryn M Rexrode; Christine M Albert; David Hunter; JoAnn E Manson
Journal:  JAMA       Date:  2002-04-10       Impact factor: 56.272

Review 7.  Postmenopausal hormone therapy and atherosclerotic disease.

Authors:  J E Manson
Journal:  Am Heart J       Date:  1994-12       Impact factor: 4.749

8.  Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.

Authors:  J R Downs; M Clearfield; S Weis; E Whitney; D R Shapiro; P A Beere; A Langendorfer; E A Stein; W Kruyer; A M Gotto
Journal:  JAMA       Date:  1998-05-27       Impact factor: 56.272

Review 9.  National High Blood Pressure Education Program Working Group Report on Hypertension in the Elderly. National High Blood Pressure Education Program Working Group.

Authors: 
Journal:  Hypertension       Date:  1994-03       Impact factor: 10.190

10.  A pilot study of ex vivo gene therapy for homozygous familial hypercholesterolaemia.

Authors:  M Grossman; D J Rader; D W Muller; D M Kolansky; K Kozarsky; B J Clark; E A Stein; P J Lupien; H B Brewer; S E Raper
Journal:  Nat Med       Date:  1995-11       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.